Ruijin Neurobank of Alzheimer's Disease and Dementia
NCT05623124 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 400
Last updated 2024-11-25
Summary
The goal of this observational study is to learn about neuroimage and biomarkers in the Alzheimer's continuum. The main questions it aims to answer are:
* How is the neurovascular coupling during AD pathogenesis?
* How is the pattern/mapping of alterations in AD biomarkers? Participants will be observed and visit the research center annually to perform multi-modal MRI, PET, neuropsychological tests, and blood tests.
Conditions
Interventions
- OTHER
-
No intervention
No intervention
Sponsors & Collaborators
-
Ruijin Hospital
lead OTHER
Eligibility
- Min Age
- 50 Years
- Max Age
- 90 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2021-11-22
- Primary Completion
- 2025-10-01
- Completion
- 2025-10-01
Countries
- China
Study Locations
More Related Trials
-
Study on Novel Peripheral Blood Diagnostic Biomarkers for MCI Due to Alzheimer's Disease
NCT04509271 ·Status: UNKNOWN
-
The Diagnostic Cut-off Value of Core Biomarkers of Alzheimer's Disease
NCT05020106 ·Status: RECRUITING
-
Biomarker Study to Diagnose Alzheimer's Disease
NCT01874418 ·Status: UNKNOWN ·Phase: NA
-
A Bridging Study on Efficacy and Safety of [18F]Florbetaben PET for Diagnosis of Alzheimer Disease Subjects in Chinese Population
NCT05527288 ·Status: COMPLETED ·Phase: NA
-
The Role of Ophthalmologic Tests and EEG Imaging in Alzheimer's Disease
NCT04277767 ·Status: UNKNOWN
-
Explore Biomarkers of Motor Neuron Disease/Frontal Dementia Spectrum Disease in China
NCT04961450 ·Status: ENROLLING_BY_INVITATION
-
Alzheimer's Disease Multinuclear Imaging Neuro-Enhanced Resolution (AD-MINER)
NCT07089303 ·Status: RECRUITING
-
Renji Alzheimer's Disease Neuroimaging Cohort Study
NCT05433363 ·Status: UNKNOWN
-
Multi-modality MRI Study on Prediction for Mild Cognitive Impairment Conversion
NCT02353884 ·Status: COMPLETED
-
Multimodal Biomarkers for Diagnosis and Prognosis in VCI
NCT04604600 ·Status: UNKNOWN ·Phase: PHASE3
-
Construction of Diagnosis System for Early AD Based on Multi-Modality MRI Technology
NCT02353845 ·Status: COMPLETED
-
Amyloid-beta PET Imaging With 18F-92 in Alzheimer's Disease
NCT04926272 ·Status: UNKNOWN ·Phase: PHASE2
-
Multi-modality MRI Study on Differences in Conversion of aMCI Patients With APOEε4 to AD
NCT02225964 ·Status: COMPLETED
-
Imaging Inflammation in Alzheimer's Disease
NCT02831283 ·Status: COMPLETED ·Phase: PHASE2
-
Study to Understand Novel Biomarkers in Researching Dementia
NCT06547099 ·Status: RECRUITING
-
Brain-heart Interaction in Coronary Plaque Stability and Cardiovascular Events
NCT05545618 ·Status: UNKNOWN
-
MRI of Alzheimer's Disease Imaging Amyloid Plaques in Persons With and Without Memory Problems
NCT00413621 ·Status: COMPLETED
-
The Mechanism Study of Diabetic Pancreatic Amyloid Deposition on Cognitive Dysfunction in Alzheimer's Disease
NCT05372458 ·Status: UNKNOWN
-
[18F]AV45(Aβ) and [18F]AV1451(Tau)PET/CT in the Diagnosis of Early Pathological Changes of Alzheimer's Disease
NCT06833645 ·Status: RECRUITING
-
Tau Protein and SV2a Imaging in Patients With Tau Protein-related Diseases
NCT05260151 ·Status: UNKNOWN
-
Detecting Early Alzheimer's Using MR
NCT05614310 ·Status: RECRUITING
-
Safety and Efficacy of Positron Emission Tomography (PET) Imaging With MNI-558
NCT01217021 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Magnetic Resonance Imaging-based Comparative Research in Different Mild Cognitive Impairment Subtype
NCT02706210 ·Status: UNKNOWN
-
Cognitive Function and Prevalence of Amyloid Marker in Frail Older Adults
NCT03129269 ·Status: COMPLETED ·Phase: NA
-
Application of Amyloid PET in Cerebral Amyloid Angiopathy
NCT03542656 ·Status: COMPLETED ·Phase: PHASE3